index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

CaVβs Muscle Biology NAD+ Inhibitors Mitochondrial fission Dystrophine Clinical trials Energy Metabolism/drug effects BMD Long noncoding RNA CaV subunits Dystrophin central domain Mdx mouse Calcium Channels LKB1 Animals Long QT LncRNA Autophagy Exon skipping Gene expression Muscular dystrophy Calcium Humans Duchenne DMD dystrophy Muscles/physiopathology Becker muscular dystrophy Drp1 DMO Gene Expression Regulation/drug effects NNOS Cell Biology Duchenne muscular dystrophy DMD Dystrophin Becker BMD muscular dystrophy Multiresolution modeling Immunoglobulin Fc Fragments/pharmacology Cardiomyopathie Myogenesis Dystrophie Musculaire de Duchenne DMD Muscular Dystrophy Muscle development Duchenne muscular dystrophy Muscular Atrophy Morphogenesis Dystrophie musculaire de Becker Molecular docking Gene modifiers Cell Line Inbred mdx Hepatocellular carcinoma Delivery Génomique Molecular Sequence Data Invivo Genomic Animal/physiopathology Knockout MiARN Male Diseases Inbred C57BL Skeletal muscle Cell homeostasis Becker muscular dystrophy BMD Muscle Strength CTNNB1 LncARN Cardiomyopathy DMD Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dynamin 2 Mice Base Sequence Activin Receptors Multi exon skipping Cells Liver L-Type Epigenetics Cultured Multi resolution modeling Dystrophy Homeostasis Modificateurs de gènes Antisense oligonucleotides Cachexia Muscle Hear Ex-vivo Myotendinous junction Human Umbilical Vein Endothelial Cells Dystrophie Musculaire de Becker BMD Metabolism DHPR α1S Dystrophin-EGFP MES Centronuclear myopathy Allele‐specific silencing therapy CD38